Effects of Topoisomerase I-targeted Drugs on Radiation Response of L5178Y Sublines Differentially Radiation and Drug Sensitive

References

• Alexander P., Mikulski Z.B. Mouse lymphoma cells with different radiosensitivities. Nature 1961; 192: 572–573
   PubMed Web of Science ®Google Scholar
• Alper T. Cellular Radiobiology. Cambridge University Press, Cambridge 1979; 193–193
   Google Scholar
• Beer J.Z., Budzicka E., Niepokojczycka E., Rosiek O., Szumiel I., Walicka M. Loss of tumorigenicity with simultaneous changes in radiosensitivity and photosensitivity during in vitro growth of L5178Y murine lymphoma cells. Cancer Research 1983; 43: 4736–4742
   PubMed Web of Science ®Google Scholar
• Boorstein R.J., Pardee A.B. β-Lapachone greatly enhances MMS lethality to human fibroblasts. Biochemical and Biophysical Research Communications 1984; 118: 828–834
   PubMedGoogle Scholar
• Boothman D.A. Enhanced malignant transformation is accompanied by increased survival recovery after ionizing radiation in Chinese hamster embryo fibroblasts. Radiation Research 1994; 138: S121–S125
   PubMedGoogle Scholar
• Boothman D.A., Greer S., Pardee A.B. Potentiation of halogenated pyrimidine radiosensitizes in human carcinoma cells by β-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphto- [1,2-b]pyran-5,6-dione), a novel DNA repair inhibitor. Cancer Research 1987; 47: 5361–5366
   PubMed Web of Science ®Google Scholar
• Boothman D.A., Trask D.K., Pardee A.B. Inhibition of potentially lethal DNA damage repair in human tumor cells by β-lapachone, an activator of topoisomerase I. Cancer Research 1989; 49: 605–612
   PubMed Web of Science ®Google Scholar
• Boothman D.A., Wang M., Schea R.A., Burrows H.L., Strickfaden S., Owens J.K. Post-treatment exposure to campotecin enhances the lethal effects of X-rays on radioresistant human malignant melanoma cells. International Journal of Radiation Oncology, Biology and Physics 1992; 24: 939–948
   PubMed Web of Science ®Google Scholar
• Boreham D.R., Trivedi A., Weinberger P., Mitchel R.E.J. The involvement of topoisomerases and DNA polymerase I in the mechanism of induced thermal and radiation resistance in yeast. Radiation Research 1990; 123: 203–212
   PubMedGoogle Scholar
• Carmichael J., Hickson I.D. Mechanisms of cellular resistance to cytotoxic drugs and X-irradiation. International Journal of Radiation Oncology, Biology and Physics 1991; 20: 197–202
   PubMed Web of Science ®Google Scholar
• Chiu S.M., Sokany N.M., Friedman L.R., Oleinick N.L. Differential processing of ultraviolet or ionizing radiation induced DNA-protein crosslinks in Chinese hamster cells. International Journal of Radiation Biology 1984; 46: 681–690
   Web of Science ®Google Scholar
• De Salvia R., Degrasi F., Berghella L., Fiore M. (1991) Effects of topoisomerase I inhibition or activation on X-ray-induced chromosomal aberrations. 21nd Meeting of the European Environmental Mutagen Society, Prague, August, 25–311991. EEMS, Prague, Abstracts Book, P-1-11
   Google Scholar
• Downes C.S., Johnson R.T. DNA topoisomerases and DNA repair. BioEssays 1988; 8: 179–184
   PubMed Web of Science ®Google Scholar
• Evans H.H., Ricanati M., Horng M., Mencl J. Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains. Mutation Research 1989; 217: 53–63
   PubMed Web of Science ®Google Scholar
• Falk S.J., Smith P.J. DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells. International Journal of Radiation Biology 1992; 61: 749–757
   PubMed Web of Science ®Google Scholar
• Gordon D.J., Milner A.E., Vaughan A.T.M., Chipman J.K. The use of flow cytometry in the detection of radiation- and chemically induced nuclear damage in human mononuclear cells. Mutagenesis 1984; 4: 35–38
   Google Scholar
• Hickson I.D., Davies S.L., Davies S.M., Robson C.N. DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases. International Journal of Radiation Biology 1990; 58: 561–568
   PubMed Web of Science ®Google Scholar
• Hsiang Y.H., Liu L.F. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Research 1988; 48: 1722–1726
   PubMed Web of Science ®Google Scholar
• Johnstone A., McNerney R. Changes in topoisomerase I activity after irradiation of lymphoid cells. Bioscience Reports 1985; 5: 907–912
   PubMed Web of Science ®Google Scholar
• Kim J.H., Kim S.H., Kolozsvary A., Khil M.S. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I. International Journal of Radiation Oncology, Biology and Physics 1992; 22: 515–518
   PubMed Web of Science ®Google Scholar
• Kowalska-Loth B., Staron K., Buraczewska I., Szumiel I., Kapiszewska M., Lange C.S. Reduced sensitivity to camptothecin of topoisomerase I from a L5178Y mouse lymphoma subline sensitive to X-radiation. Biochimica et Biophysica Acta 1993; 1172: 117–123
   PubMed Web of Science ®Google Scholar
• Li J.Q., Pardee A.B. Enhanced lethality to human breast cancer cells of neocarcinostatin by camptothecin and beta-lapachone, a novel DNA topoisomerase I modulator with a different mode of action from camptothecin. Proceedings of the Annual Meeting of American Association for Cancer Research 33. 1992, A2585 (Abs)
   Google Scholar
• Li C.J., Averboukh I., Pardee A.B. β-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. Journal of Biological Chemistry 1993; 268: 22463–22468
   PubMed Web of Science ®Google Scholar
• Mattern M.R., Hofmann G.A., McCabe F.L., Johnson R.K. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). Cancer Research 1991; 51: 5813–5816
   PubMed Web of Science ®Google Scholar
• Musk S.R.R., Stell G.G. The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase. British Journal of Cancer 1992; 62: 364–267
   Google Scholar
• Ryan A.J., Squires S., Strutt H.L., Johnson R.T. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Research 1991; 19: 3295–3300
   PubMed Web of Science ®Google Scholar
• Slichenmyer W.J., Rowinsky E.C., Donehower R.C., Kaufmann S.H. The current status of camptothecin analogues as antitumor agents. Journal of the National Cancer Institute 1993; 65: 211–291
   Google Scholar
• Smith P.J. DNA topoisomerases and radiation responses. International Journal of Radiation Biology 1990; 58: 553–559
   PubMed Web of Science ®Google Scholar
• Smith P.J., Makinson T.A., Watson J.V. Enhanced sensitivity to camptothecin in ataxia telangiectasia cells and its relationship with the expression of DNA topoisomerase I. International Journal of Radiation Biology 1989; 55: 217–231
   PubMed Web of Science ®Google Scholar
• Staron K., Kowalska-Loth B., Zabek J., Czerwinski R.M., Szumiel I. Topoisomerase I is differently phosphorylated in two strains of L5178Y mouse lymphoma cells. Biochimica et Biophysica Acta 1995; 1260: 35–42
   PubMedGoogle Scholar
• Szumiel I. Response of two strains of L5178Y cells to cis-dichlorobis (cyclopentylamine) platinum (II). I. Cross-sensitivity to cis-PAD and UV light. Chemical and Biological Interactions 1979; 24: 51–72
   PubMed Web of Science ®Google Scholar
• Warters R.L., Lyons B.W., Kennedy K., Li M.T. Topoisomerase activity in irradiated mammalian cells. Mutation Research 1989; 216: 43–55
   PubMedGoogle Scholar
• Wilson G.D., McNally N.J., Dunphy E., Kracher H., Pfagner R. The labelling index of human and mouse tumors assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 1985; 6: 641–647
   PubMedGoogle Scholar
• Woldek D., Hittelman W.N. The repair of double-strand DNA breaks correlates with radiosensitivity of L5178Y-S and L5178Y-R cells. Radiation Research 1987; 112: 146–155
   PubMedGoogle Scholar